January 1, 2018 marked the start of the four-year Danish trial scheme for the treatment of patients with medical cannabis. A framework has thereby been created to help a number of patient groups and generate new knowledge and further evidence of the efficacy of medical cannabis.
It's important for us to be part of the collaboration between patients, doctors, researchers and manufacturers. That's why we will gladly share our knowledge and discuss the potential as well as any potential challenges of medical cannabis.
During the trial scheme, Spectrum Cannabis obtained a permit from the Danish Medicines Agency to cultivate and develop cannabis products, as well as company authorisation for the preparation of cannabis intermediate products.